ARRY-520
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ARRY-520, covering 2020-10-19 to 2021-02-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study of ARRY-520 in Patients With Advanced Myeloid Leukemia [Phase 1, Phase 2]